CHRNA9 and glioma: The relationship between primary therapy outcome, Age, CHRNA9 expression level, WHO grade, IDH status, 1-year, 3-year, and 5-year survival prognosis of glioma was evaluated by nomogram [C-index: 0.849 (0.830-0.867), Figure 3A].